Global Carmustine Market Research Report 2021

Publisher Name :
Date: 25-Feb-2021
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 100mg Injection

- 125mg Injection

Segment by Application

- Glioma

- Glioblastoma Multiforme

- Medulloblastoma and Astrocytoma

- Multiple Myeloma

- Lymphoma

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Amneal Pharms

- Arbor Pharms

- Emcure Pharms

- Navinta

- STI Pharma

- Obvius Pharmaceuticals

- MGI Pharma

- Marcan Pharmaceuticals

- Eisai

- Bristol-Myers Squibb

- Pharmaplan

- Sanli Ilac

- Zydus Pharmaceuticals 

- Tianjin Kingyork

Global Carmustine Market Research Report 2021

Table of Contents
1 Carmustine Market Overview
1.1 Product Overview and Scope of Carmustine
1.2 Carmustine Segment by Type
1.2.1 Global Carmustine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 100mg Injection
1.2.3 125mg Injection
1.3 Carmustine Segment by Application
1.3.1 Carmustine Sales Comparison by Application: (2021-2027)
1.3.2 Glioma
1.3.3 Glioblastoma Multiforme
1.3.4 Medulloblastoma and Astrocytoma
1.3.5 Multiple Myeloma
1.3.6 Lymphoma
1.3.7 Other
1.4 Global Carmustine Market Size Estimates and Forecasts
1.4.1 Global Carmustine Revenue 2016-2027
1.4.2 Global Carmustine Sales 2016-2027
1.4.3 Carmustine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Carmustine Market Competition by Manufacturers
2.1 Global Carmustine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Carmustine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Carmustine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Carmustine Manufacturing Sites, Area Served, Product Type
2.5 Carmustine Market Competitive Situation and Trends
2.5.1 Carmustine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Carmustine Players Market Share by Revenue
2.5.3 Global Carmustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carmustine Retrospective Market Scenario by Region
3.1 Global Carmustine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Carmustine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Carmustine Market Facts & Figures by Country
3.3.1 North America Carmustine Sales by Country
3.3.2 North America Carmustine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Carmustine Market Facts & Figures by Country
3.4.1 Europe Carmustine Sales by Country
3.4.2 Europe Carmustine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Carmustine Market Facts & Figures by Region
3.5.1 Asia Pacific Carmustine Sales by Region
3.5.2 Asia Pacific Carmustine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Carmustine Market Facts & Figures by Country
3.6.1 Latin America Carmustine Sales by Country
3.6.2 Latin America Carmustine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Carmustine Market Facts & Figures by Country
3.7.1 Middle East and Africa Carmustine Sales by Country
3.7.2 Middle East and Africa Carmustine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Carmustine Historic Market Analysis by Type
4.1 Global Carmustine Sales Market Share by Type (2016-2021)
4.2 Global Carmustine Revenue Market Share by Type (2016-2021)
4.3 Global Carmustine Price by Type (2016-2021)
5 Global Carmustine Historic Market Analysis by Application
5.1 Global Carmustine Sales Market Share by Application (2016-2021)
5.2 Global Carmustine Revenue Market Share by Application (2016-2021)
5.3 Global Carmustine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amneal Pharms
6.1.1 Amneal Pharms Corporation Information
6.1.2 Amneal Pharms Description and Business Overview
6.1.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amneal Pharms Product Portfolio
6.1.5 Amneal Pharms Recent Developments/Updates
6.2 Arbor Pharms
6.2.1 Arbor Pharms Corporation Information
6.2.2 Arbor Pharms Description and Business Overview
6.2.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Arbor Pharms Product Portfolio
6.2.5 Arbor Pharms Recent Developments/Updates
6.3 Emcure Pharms
6.3.1 Emcure Pharms Corporation Information
6.3.2 Emcure Pharms Description and Business Overview
6.3.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Emcure Pharms Product Portfolio
6.3.5 Emcure Pharms Recent Developments/Updates
6.4 Navinta
6.4.1 Navinta Corporation Information
6.4.2 Navinta Description and Business Overview
6.4.3 Navinta Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Navinta Product Portfolio
6.4.5 Navinta Recent Developments/Updates
6.5 STI Pharma
6.5.1 STI Pharma Corporation Information
6.5.2 STI Pharma Description and Business Overview
6.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 STI Pharma Product Portfolio
6.5.5 STI Pharma Recent Developments/Updates
6.6 Obvius Pharmaceuticals
6.6.1 Obvius Pharmaceuticals Corporation Information
6.6.2 Obvius Pharmaceuticals Description and Business Overview
6.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Obvius Pharmaceuticals Product Portfolio
6.6.5 Obvius Pharmaceuticals Recent Developments/Updates
6.7 MGI Pharma
6.6.1 MGI Pharma Corporation Information
6.6.2 MGI Pharma Description and Business Overview
6.6.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MGI Pharma Product Portfolio
6.7.5 MGI Pharma Recent Developments/Updates
6.8 Marcan Pharmaceuticals
6.8.1 Marcan Pharmaceuticals Corporation Information
6.8.2 Marcan Pharmaceuticals Description and Business Overview
6.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Marcan Pharmaceuticals Product Portfolio
6.8.5 Marcan Pharmaceuticals Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Eisai Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bristol-Myers Squibb Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Pharmaplan
6.11.1 Pharmaplan Corporation Information
6.11.2 Pharmaplan Carmustine Description and Business Overview
6.11.3 Pharmaplan Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pharmaplan Product Portfolio
6.11.5 Pharmaplan Recent Developments/Updates
6.12 Sanli Ilac
6.12.1 Sanli Ilac Corporation Information
6.12.2 Sanli Ilac Carmustine Description and Business Overview
6.12.3 Sanli Ilac Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sanli Ilac Product Portfolio
6.12.5 Sanli Ilac Recent Developments/Updates
6.13 Zydus Pharmaceuticals 
6.13.1 Zydus Pharmaceuticals  Corporation Information
6.13.2 Zydus Pharmaceuticals  Carmustine Description and Business Overview
6.13.3 Zydus Pharmaceuticals  Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Zydus Pharmaceuticals  Product Portfolio
6.13.5 Zydus Pharmaceuticals  Recent Developments/Updates
6.14 Tianjin Kingyork
6.14.1 Tianjin Kingyork Corporation Information
6.14.2 Tianjin Kingyork Carmustine Description and Business Overview
6.14.3 Tianjin Kingyork Carmustine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Tianjin Kingyork Product Portfolio
6.14.5 Tianjin Kingyork Recent Developments/Updates
7 Carmustine Manufacturing Cost Analysis
7.1 Carmustine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Carmustine
7.4 Carmustine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Carmustine Distributors List
8.3 Carmustine Customers
9 Carmustine Market Dynamics
9.1 Carmustine Industry Trends
9.2 Carmustine Growth Drivers
9.3 Carmustine Market Challenges
9.4 Carmustine Market Restraints
10 Global Market Forecast
10.1 Carmustine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Carmustine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Carmustine by Type (2022-2027)
10.2 Carmustine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Carmustine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Carmustine by Application (2022-2027)
10.3 Carmustine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Carmustine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Carmustine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Carmustine Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Carmustine Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Carmustine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Carmustine Covered in This Study
Table 5. Global Carmustine Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Carmustine Sales Share by Manufacturers (2016-2021)
Table 7. Global Carmustine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Carmustine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Carmustine Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Carmustine Manufacturing Sites and Area Served
Table 11. Manufacturers Carmustine Product Type
Table 12. Global Carmustine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Carmustine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carmustine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Carmustine Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Carmustine Sales Market Share by Region (2016-2021)
Table 17. Global Carmustine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Carmustine Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Carmustine Sales Market Share by Country (2016-2021)
Table 20. North America Carmustine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Carmustine Revenue Market Share by Country (2016-2021)
Table 22. Europe Carmustine Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Carmustine Sales Market Share by Country (2016-2021)
Table 24. Europe Carmustine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Carmustine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Carmustine Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Carmustine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Carmustine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Carmustine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Carmustine Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Carmustine Sales Market Share by Country (2016-2021)
Table 32. Latin America Carmustine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Carmustine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Carmustine Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Carmustine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Carmustine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Carmustine Revenue Market Share by Country (2016-2021)
Table 38. Global Carmustine Sales (K Pcs) by Type (2016-2021)
Table 39. Global Carmustine Sales Market Share by Type (2016-2021)
Table 40. Global Carmustine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Carmustine Revenue Share by Type (2016-2021)
Table 42. Global Carmustine Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Carmustine Sales (K Pcs) by Application (2016-2021)
Table 44. Global Carmustine Sales Market Share by Application (2016-2021)
Table 45. Global Carmustine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Carmustine Revenue Share by Application (2016-2021)
Table 47. Global Carmustine Price (USD/Pcs) by Application (2016-2021)
Table 48. Amneal Pharms Corporation Information
Table 49. Amneal Pharms Description and Business Overview
Table 50. Amneal Pharms Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Amneal Pharms Carmustine Product
Table 52. Amneal Pharms Recent Developments/Updates
Table 53. Arbor Pharms Corporation Information
Table 54. Arbor Pharms Description and Business Overview
Table 55. Arbor Pharms Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Arbor Pharms Carmustine Product
Table 57. Arbor Pharms Recent Developments/Updates
Table 58. Emcure Pharms Corporation Information
Table 59. Emcure Pharms Description and Business Overview
Table 60. Emcure Pharms Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Emcure Pharms Carmustine Product
Table 62. Emcure Pharms Recent Developments/Updates
Table 63. Navinta Corporation Information
Table 64. Navinta Description and Business Overview
Table 65. Navinta Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Navinta Carmustine Product
Table 67. Navinta Recent Developments/Updates
Table 68. STI Pharma Corporation Information
Table 69. STI Pharma Description and Business Overview
Table 70. STI Pharma Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. STI Pharma Carmustine Product
Table 72. STI Pharma Recent Developments/Updates
Table 73. Obvius Pharmaceuticals Corporation Information
Table 74. Obvius Pharmaceuticals Description and Business Overview
Table 75. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Obvius Pharmaceuticals Carmustine Product
Table 77. Obvius Pharmaceuticals Recent Developments/Updates
Table 78. MGI Pharma Corporation Information
Table 79. MGI Pharma Description and Business Overview
Table 80. MGI Pharma Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. MGI Pharma Carmustine Product
Table 82. MGI Pharma Recent Developments/Updates
Table 83. Marcan Pharmaceuticals Corporation Information
Table 84. Marcan Pharmaceuticals Description and Business Overview
Table 85. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Marcan Pharmaceuticals Carmustine Product
Table 87. Marcan Pharmaceuticals Recent Developments/Updates
Table 88. Eisai Corporation Information
Table 89. Eisai Description and Business Overview
Table 90. Eisai Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Eisai Carmustine Product
Table 92. Eisai Recent Developments/Updates
Table 93. Bristol-Myers Squibb Corporation Information
Table 94. Bristol-Myers Squibb Description and Business Overview
Table 95. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Bristol-Myers Squibb Carmustine Product
Table 97. Bristol-Myers Squibb Recent Developments/Updates
Table 98. Pharmaplan Corporation Information
Table 99. Pharmaplan Description and Business Overview
Table 100. Pharmaplan Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Pharmaplan Carmustine Product
Table 102. Pharmaplan Recent Developments/Updates
Table 103. Sanli Ilac Corporation Information
Table 104. Sanli Ilac Description and Business Overview
Table 105. Sanli Ilac Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Sanli Ilac Carmustine Product
Table 107. Sanli Ilac Recent Developments/Updates
Table 108. Zydus Pharmaceuticals  Corporation Information
Table 109. Zydus Pharmaceuticals  Description and Business Overview
Table 110. Zydus Pharmaceuticals  Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Zydus Pharmaceuticals  Carmustine Product
Table 112. Zydus Pharmaceuticals  Recent Developments/Updates
Table 113. Tianjin Kingyork Corporation Information
Table 114. Tianjin Kingyork Description and Business Overview
Table 115. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Tianjin Kingyork Carmustine Product
Table 117. Tianjin Kingyork Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Carmustine Distributors List
Table 121. Carmustine Customers List
Table 122. Carmustine Market Trends
Table 123. Carmustine Growth Drivers
Table 124. Carmustine Market Restraints
Table 125. Global Carmustine Sales Forecast by Type (2022-2027) & (K Pcs)
Table 126. Global Carmustine Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Carmustine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Carmustine Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Carmustine Sales Forecast by Application (2022-2027) & (K Pcs)
Table 130. Global Carmustine Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Carmustine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Carmustine Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Carmustine Sales Forecast by Region (2022-2027) & (K Pcs)
Table 134. Global Carmustine Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Carmustine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Carmustine Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carmustine
Figure 2. Global Carmustine Market Share by Type in 2020 & 2027
Figure 3. 100mg Injection Product Picture
Figure 4. 125mg Injection Product Picture
Figure 5. Global Carmustine Market Share by Application in 2020 & 2027
Figure 6. Glioma
Figure 7. Glioblastoma Multiforme
Figure 8. Medulloblastoma and Astrocytoma
Figure 9. Multiple Myeloma
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Carmustine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Carmustine Market Size 2016-2027 (US$ Million)
Figure 14. Global Carmustine Sales 2016-2027 (K Pcs)
Figure 15. Global Carmustine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Carmustine Sales Share by Manufacturers in 2020
Figure 17. Global Carmustine Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Carmustine Players: Market Share by Revenue in 2020
Figure 19. Carmustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Carmustine Sales Market Share by Region (2016-2021)
Figure 21. Global Carmustine Sales Market Share by Region in 2020
Figure 22. Global Carmustine Revenue Market Share by Region (2016-2021)
Figure 23. Global Carmustine Revenue Market Share by Region in 2020
Figure 24. U.S. Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Carmustine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Carmustine by Type (2016-2021)
Figure 49. Sales Market Share of Carmustine by Application (2016-2021)
Figure 50. Sales Market Share of Carmustine by Application in 2020
Figure 51. Revenue Share of Carmustine by Application (2016-2021)
Figure 52. Revenue Share of Carmustine by Application in 2020
Figure 53. Manufacturing Cost Structure of Carmustine
Figure 54. Manufacturing Process Analysis of Carmustine
Figure 55. Carmustine Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs